Additional Benefit from Radial Artery Graft in Myocardial Revascularization Surgery

Used to different extents according to institution, surgeon, and historical time, the radial artery graft is yet to prove whether it can improve the outcomes of myocardial revascularization surgery when added to a single or bilateral internal thoracic artery graft.

¿Beneficio adicional del bypass radial en la cirugía de revascularización miocárdica?

The ART (Arterial Revascularization Trial) was designed to compare survival after bilateral vs. single left internal thoracic artery graft. In the ART, a large proportion of patients (20%) received a radial artery graft instead of a saphenous vein graft; in consequence, this analysis post hoc aimed to investigate any additional benefits.


Read also: Myocardial Revascularization Surgery: One or Two Internal-Thoracic-Artery Grafts?”


Among the 3102 patients enrolled, 632 received a radial artery graft additional to the single or bilateral internal thoracic artery graft, and 2105 patients received a saphenous vein graft.

 

The primary endpoint was a composite of acute myocardial infarction, cardiovascular death, and repeat revascularization at 5 years.

 

The combined endpoint was significantly lower in the radial artery graft group (8.8% vs. 13.6%; p = 0.005), mainly due to a lower rate of repeat revascularization (4.4% vs. 7.6%).


Read also: Striking Finding on Diabetes and Bypass Graft Patency”.


This association was present in patients who received a single or a bilateral internal thoracic artery graft, indistinctively.

 

Conclusion

This post hoc ART analysis showed that an additional radial artery graft was associated with less events at 5 years when used to supplement single or bilateral internal thoracic artery grafts.

 

Editorial

Angiographic follow-up was carried out only in symptomatic patients, which means that graft patency could not be assessed. However, all patients who required graft revascularization had a saphenous vein graft instead of a radial artery graft.

 

The ART interim analysis at 5 years shows that bilateral internal thoracic artery grafts are not superior to single left internal thoracic artery grafts, although any difference in that regard would be expected much later. Maybe the 10-year follow-up will have good news for complete artery revascularization.

 

Original title: Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes. Insights from the Arterial Revascularization Trial.

Reference: David P. Taggart et al. Circulation. 2017 Aug 1;136(5):454-463.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....